-
1
-
-
84055193439
-
Plasmid-mediated resistance in Enterobacteriaceae: Changing landscape and implications for therapy
-
Schultsz C, Geerlings S. 2012. Plasmid-mediated resistance in Enterobacteriaceae: changing landscape and implications for therapy. Drugs 72: 1-16.
-
(2012)
Drugs
, vol.72
, pp. 1-16
-
-
Schultsz, C.1
Geerlings, S.2
-
2
-
-
84858597297
-
Current trends in culture-based and molecular detection of extended-spectrumbeta-lactamase-harboring and carbapenem-resistant Enterobacteriaceae
-
Gazin M, Paasch F, Goossens H, Malhotra-Kumar S. 2012. Current trends in culture-based and molecular detection of extended-spectrumbeta-lactamase- harboring and carbapenem-resistant Enterobacteriaceae. J. Clin. Microbiol. 50:1140-1146.
-
(2012)
J. Clin. Microbiol.
, vol.50
, pp. 1140-1146
-
-
Gazin, M.1
Paasch, F.2
Goossens, H.3
Malhotra-Kumar, S.4
-
3
-
-
80053572626
-
Genetic evolution and clinical impact in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae
-
Chong Y, Ito Y, Kamimura T. 2011. Genetic evolution and clinical impact in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Infect. Genet. Evol. 11:1499-1504.
-
(2011)
Infect. Genet. Evol.
, vol.11
, pp. 1499-1504
-
-
Chong, Y.1
Ito, Y.2
Kamimura, T.3
-
4
-
-
39049128343
-
Extended-spectrum beta-lactamaseproducing Enterobacteriaceae: An emerging public-health concern
-
Pitout JD, Laupland KB. 2008. Extended-spectrum beta-lactamaseproducing Enterobacteriaceae: an emerging public-health concern. Lancet Infect. Dis. 8:159-166.
-
(2008)
Lancet Infect. Dis.
, vol.8
, pp. 159-166
-
-
Pitout, J.D.1
Laupland, K.B.2
-
5
-
-
27144490073
-
Extended-spectrum beta-lactamases: A clinical update
-
Paterson DL, Bonomo RA. 2005. Extended-spectrum beta-lactamases: a clinical update. Clin. Microbiol. Rev. 18:657-686.
-
(2005)
Clin. Microbiol. Rev.
, vol.18
, pp. 657-686
-
-
Paterson, D.L.1
Bonomo, R.A.2
-
6
-
-
77954879314
-
Extended-spectrum betalactamase producing Escherichia coli: Changing epidemiology and clinical impact
-
Oteo J, Perez-Vazquez M, Campos J. 2010. Extended-spectrum betalactamase producing Escherichia coli: changing epidemiology and clinical impact. Curr. Opin. Infect. Dis. 23:320-326.
-
(2010)
Curr. Opin. Infect. Dis.
, vol.23
, pp. 320-326
-
-
Oteo, J.1
Perez-Vazquez, M.2
Campos, J.3
-
7
-
-
33751566651
-
Bacteremia due to extendedspectrum beta-lactamase-producing Escherichia coli in the CTX-M era: A new clinical challenge
-
Rodriguez-Bano J, Navarro MD, Romero L, Muniain MA, de Cueto M, Rios MJ, Hernandez JR, Pascual A. 2006. Bacteremia due to extendedspectrum beta-lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge. Clin. Infect. Dis. 43:1407-1414.
-
(2006)
Clin. Infect. Dis.
, vol.43
, pp. 1407-1414
-
-
Rodriguez-Bano, J.1
Navarro, M.D.2
Romero, L.3
Muniain, M.A.4
De Cueto, M.5
Rios, M.J.6
Hernandez, J.R.7
Pascual, A.8
-
8
-
-
72049128093
-
Communityonset bacteremia due to extended-spectrum beta-lactamase- producing Escherichia coli: Risk factors and prognosis
-
Rodriguez-Bano J, Picon E, Gijon P, Hernandez JR, Ruiz M, Pena C, Almela M, Almirante B, Grill F, Colomina J, Gimenez M, Oliver A, Horcajada JP, Navarro G, Coloma A, Pascual A. 2010. Communityonset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis. Clin. Infect. Dis. 50:40-48.
-
(2010)
Clin. Infect. Dis.
, vol.50
, pp. 40-48
-
-
Rodriguez-Bano, J.1
Picon, E.2
Gijon, P.3
Hernandez, J.R.4
Ruiz, M.5
Pena, C.6
Almela, M.7
Almirante, B.8
Grill, F.9
Colomina, J.10
Gimenez, M.11
Oliver, A.12
Horcajada, J.P.13
Navarro, G.14
Coloma, A.15
Pascual, A.16
-
9
-
-
79960941037
-
Cephalosporin and fluoroquinolone combinations are highly associated with CTX-M beta-lactamase-producing Escherichia coli: A case-control study in a French teaching hospital
-
Cassier P, Lallechere S, Aho S, Astruc K, Neuwirth C, Piroth L, Chavanet P. 2011. Cephalosporin and fluoroquinolone combinations are highly associated with CTX-M beta-lactamase-producing Escherichia coli: a case-control study in a French teaching hospital. Clin. Microbiol. Infect. 17:1746-1751.
-
(2011)
Clin. Microbiol. Infect.
, vol.17
, pp. 1746-1751
-
-
Cassier, P.1
Lallechere, S.2
Aho, S.3
Astruc, K.4
Neuwirth, C.5
Piroth, L.6
Chavanet, P.7
-
10
-
-
35848969143
-
First report of the emergence of CTX-M-type extended-spectrum betalactamases (ESBLs) as the predominant ESBL isolated in a U.S
-
Lewis JS, II, Herrera M, Wickes B, Patterson JE, Jorgensen JH. 2007. First report of the emergence of CTX-M-type extended-spectrum betalactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system. Antimicrob. Agents Chemother. 51:4015-4021.
-
(2007)
Health Care System. Antimicrob. Agents Chemother.
, vol.51
, pp. 4015-4021
-
-
Lewis, J.S.1
Herrera, M.2
Wickes, B.3
Patterson, J.E.4
Jorgensen, J.H.5
-
11
-
-
24044511840
-
Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community
-
Pitout JD, Nordmann P, Laupland KB, Poirel L. 2005. Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. J. Antimicrob. Chemother. 56:52-59.
-
(2005)
J. Antimicrob. Chemother.
, vol.56
, pp. 52-59
-
-
Pitout, J.D.1
Nordmann, P.2
Laupland, K.B.3
Poirel, L.4
-
12
-
-
84860204494
-
Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25:H4) and blaCTX-M-15 among extendedspectrum-beta-lactamase-producing e coli from the United States, 2000 to 2009
-
Johnson JR, Urban C, Weissman SJ, Jorgensen JH, Lewis JS, II, Hansen G, Edelstein PH, Robicsek A, Cleary T, Adachi J, Paterson D, Quinn J, Hanson ND, Johnston BD, Clabots C, Kuskowski MA, AMERICUS Investigators. 2012. Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25:H4) and blaCTX-M-15 among extendedspectrum-beta-lactamase-producing E. coli from the United States, 2000 to 2009. Antimicrob. Agents Chemother. 56:2364-2370.
-
(2012)
Antimicrob. Agents Chemother
, vol.56
, pp. 2364-2370
-
-
Johnson, J.R.1
Urban, C.2
Weissman, S.J.3
Jorgensen, J.H.4
Lewis, J.S.5
Hansen, G.6
Edelstein, P.H.7
Robicsek, A.8
Cleary, T.9
Adachi, J.10
Paterson, D.11
Quinn, J.12
Hanson, N.D.13
Johnston, B.D.14
Clabots, C.15
Kuskowski, M.A.16
-
13
-
-
78650339210
-
Escherichia coli O25b-ST131: A pandemic, multiresistant, community-associated strain
-
Rogers BA, Sidjabat HE, Paterson DL. 2011. Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J. Antimicrob. Chemother. 66:1-14.
-
(2011)
J. Antimicrob. Chemother.
, vol.66
, pp. 1-14
-
-
Rogers, B.A.1
Sidjabat, H.E.2
Paterson, D.L.3
-
14
-
-
69949093704
-
Prevalence of CTX-M beta-lactamases in Philadelphia, Pennsylvania
-
McGettigan SE, Hu B, Andreacchio K, Nachamkin I, Edelstein PH. 2009. Prevalence of CTX-M beta-lactamases in Philadelphia, Pennsylvania. J. Clin. Microbiol. 47:2970-2974.
-
(2009)
J. Clin. Microbiol.
, vol.47
, pp. 2970-2974
-
-
McGettigan, S.E.1
Hu, B.2
Andreacchio, K.3
Nachamkin, I.4
Edelstein, P.H.5
-
15
-
-
0037974508
-
Discovery of CTX-M-like extended-spectrum betalactamases in Escherichia coli isolates from five U.S
-
Moland ES, Black JA, Hossain A, Hanson ND, Thomson KS, Pottumarthy S. 2003. Discovery of CTX-M-like extended-spectrum betalactamases in Escherichia coli isolates from five U.S. states. Antimicrob. Agents Chemother. 47:2382-2383.
-
(2003)
States. Antimicrob. Agents Chemother.
, vol.47
, pp. 2382-2383
-
-
Moland, E.S.1
Black, J.A.2
Hossain, A.3
Hanson, N.D.4
Thomson, K.S.5
Pottumarthy, S.6
-
16
-
-
77953024695
-
Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: High prevalence of ST131 producing CTX-M-15 in community hospitals
-
Peirano G, Costello M, Pitout JD. 2010. Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals. Int. J. Antimicrob. Agents 36:19-23.
-
(2010)
Int. J. Antimicrob. Agents
, vol.36
, pp. 19-23
-
-
Peirano, G.1
Costello, M.2
Pitout, J.D.3
-
17
-
-
51349130520
-
Rapid emergence of blaCTX-M among Enterobacteriaceae in U.S medical centers: Molecular evaluation from the MYSTIC Program (2007)
-
Castanheira M, Mendes RE, Rhomberg PR, Jones RN. 2008. Rapid emergence of blaCTX-M among Enterobacteriaceae in U.S. medical centers: molecular evaluation from the MYSTIC Program (2007). Microb. Drug Resist. 14:211-216.
-
(2008)
Microb. Drug Resist.
, vol.14
, pp. 211-216
-
-
Castanheira, M.1
Mendes, R.E.2
Rhomberg, P.R.3
Jones, R.N.4
-
18
-
-
0037097507
-
Control-group selection importance in studies of antimicrobial resistance: Examples applied to Pseudomonas aeruginosa, enterococci, and Escherichia coli
-
Harris AD, Samore MH, Lipsitch M, Kaye KS, Perencevich E, Carmeli Y. 2002. Control-group selection importance in studies of antimicrobial resistance: examples applied to Pseudomonas aeruginosa, enterococci, and Escherichia coli. Clin. Infect. Dis. 34:1558-1563.
-
(2002)
Clin. Infect. Dis.
, vol.34
, pp. 1558-1563
-
-
Harris, A.D.1
Samore, M.H.2
Lipsitch, M.3
Kaye, K.S.4
Perencevich, E.5
Carmeli, Y.6
-
19
-
-
17444391264
-
The case-case-control study design: Addressing the limitations of risk factor studies for antimicrobial resistance
-
Kaye KS, Harris AD, Samore M, Carmeli Y. 2005. The case-case-control study design: addressing the limitations of risk factor studies for antimicrobial resistance. Infect. Control Hosp. Epidemiol. 26:346-351.
-
(2005)
Infect. Control Hosp. Epidemiol.
, vol.26
, pp. 346-351
-
-
Kaye, K.S.1
Harris, A.D.2
Samore, M.3
Carmeli, Y.4
-
20
-
-
0023092594
-
A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
-
Charlson ME, Pompei P, Ales KL, MacKenzie CR. 1987. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic Dis. 40:373-383.
-
(1987)
J. Chronic Dis.
, vol.40
, pp. 373-383
-
-
Charlson, M.E.1
Pompei, P.2
Ales, K.L.3
Mackenzie, C.R.4
-
21
-
-
0021857405
-
Vali-dation of a prognostic score in critically ill patients undergoing transport
-
Bion JF, Edlin SA, Ramsay G, McCabe S, Ledingham IM. 1985. Vali-dation of a prognostic score in critically ill patients undergoing transport. Br. Med. J. 291:432-434.
-
(1985)
Br. Med. J.
, vol.291
, pp. 432-434
-
-
Bion, J.F.1
Edlin, S.A.2
Ramsay, G.3
McCabe, S.4
Ledingham, I.M.5
-
22
-
-
1642572165
-
Studies of illness in the aged
-
Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. 1963. Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA 185:914-919.
-
(1963)
The Index of ADL: A Standardized Measure of Biological and Psychosocial Function. JAMA
, vol.185
, pp. 914-919
-
-
Katz, S.1
Ford, A.B.2
Moskowitz, R.W.3
Jackson, B.A.4
Jaffe, M.W.5
-
23
-
-
44449164571
-
CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting
-
Horan TC, Andrus M, Dudeck MA. 2008. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am. J. Infect. Control 36:309-332.
-
(2008)
Am. J. Infect. Control
, vol.36
, pp. 309-332
-
-
Horan, T.C.1
Andrus, M.2
Dudeck, M.A.3
-
26
-
-
0035996086
-
Identification of PSE and OXA beta-lactamase genes in Pseudomonas aeruginosa using PCRrestriction fragment length polymorphism
-
Bert F, Branger C, Lambert-Zechovsky N. 2002. Identification of PSE and OXA beta-lactamase genes in Pseudomonas aeruginosa using PCRrestriction fragment length polymorphism. J. Antimicrob. Chemother. 50:11-18.
-
(2002)
J. Antimicrob. Chemother.
, vol.50
, pp. 11-18
-
-
Bert, F.1
Branger, C.2
Lambert-Zechovsky, N.3
-
27
-
-
70350321276
-
Molecular epidemiology of CTX-Mproducing Escherichia coli isolates at a tertiary medical center in western Pennsylvania
-
Sidjabat HE, Paterson DL, Adams-Haduch JM, Ewan L, Pasculle AW, Muto CA, Tian GB, Doi Y. 2009. Molecular epidemiology of CTX-Mproducing Escherichia coli isolates at a tertiary medical center in western Pennsylvania. Antimicrob. Agents Chemother. 53:4733-4739.
-
(2009)
Antimicrob. Agents Chemother.
, vol.53
, pp. 4733-4739
-
-
Sidjabat, H.E.1
Paterson, D.L.2
Adams-Haduch, J.M.3
Ewan, L.4
Pasculle, A.W.5
Muto, C.A.6
Tian, G.B.7
Doi, Y.8
-
28
-
-
33645086351
-
Influx of extended-spectrum beta-lactamase-producing enterobacteriaceae into the hospital
-
Ben-Ami R, Schwaber MJ, Navon-Venezia S, Schwartz D, Giladi M, Chmelnitsky I, Leavitt A, Carmeli Y. 2006. Influx of extended-spectrum beta-lactamase-producing enterobacteriaceae into the hospital. Clin. Infect. Dis. 42:925-934.
-
(2006)
Clin. Infect. Dis.
, vol.42
, pp. 925-934
-
-
Ben-Ami, R.1
Schwaber, M.J.2
Navon-Venezia, S.3
Schwartz, D.4
Giladi, M.5
Chmelnitsky, I.6
Leavitt, A.7
Carmeli, Y.8
-
29
-
-
78751567921
-
Risk factors and outcomes of Escherichia coli bacteremia caused by strains that produce CTX-M or non-CTX-M extended-spectrum-beta-lactamases
-
Wu UI, Wang JL, Chen WC, Chang SC, Chen YC. 2011. Risk factors and outcomes of Escherichia coli bacteremia caused by strains that produce CTX-M or non-CTX-M extended-spectrum-beta-lactamases. Eur. J. Clin. Microbiol. Infect. Dis. 30:33-39.
-
(2011)
Eur. J. Clin. Microbiol. Infect. Dis.
, vol.30
, pp. 33-39
-
-
Wu, U.I.1
Wang, J.L.2
Chen, W.C.3
Chang, S.C.4
Chen, Y.C.5
-
30
-
-
70149090868
-
A multinational survey of risk factors for infection with extendedspectrum beta-lactamase-producing Enterobacteriaceae in nonhospitalized patients
-
Ben-Ami R, Rodriguez-Bano J, Arslan H, Pitout JD, Quentin C, Calbo ES, Azap OK, Arpin C, Pascual A, Livermore DM, Garau J, Carmeli Y. 2009. A multinational survey of risk factors for infection with extendedspectrum beta-lactamase-producing Enterobacteriaceae in nonhospitalized patients. Clin. Infect. Dis. 49:682-690.
-
(2009)
Clin. Infect. Dis.
, vol.49
, pp. 682-690
-
-
Ben-Ami, R.1
Rodriguez-Bano, J.2
Arslan, H.3
Pitout, J.D.4
Quentin, C.5
Calbo, E.S.6
Azap, O.K.7
Arpin, C.8
Pascual, A.9
Livermore, D.M.10
Garau, J.11
Carmeli, Y.12
-
31
-
-
69049102137
-
Nursing homes as a reservoir of extended-spectrum beta-lactamase (ESBL)-producing ciprofloxacin-resistant Escherichia coli
-
Rooney PJ, O'Leary MC, Loughrey AC, McCalmont M, Smyth B, Donaghy P, Badri M, Woodford N, Karisik E, Livermore DM. 2009. Nursing homes as a reservoir of extended-spectrum beta-lactamase (ESBL)-producing ciprofloxacin-resistant Escherichia coli. J. Antimicrob. Chemother. 64:635-641.
-
(2009)
J. Antimicrob. Chemother.
, vol.64
, pp. 635-641
-
-
Rooney, P.J.1
O'Leary, M.C.2
Loughrey, A.C.3
McCalmont, M.4
Smyth, B.5
Donaghy, P.6
Badri, M.7
Woodford, N.8
Karisik, E.9
Livermore, D.M.10
-
32
-
-
78650290745
-
Risk factors and outcome of extended-spectrum beta-lactamaseproducing Enterobacter cloacae bloodstream infections
-
Qureshi ZA, Paterson DL, Pakstis DL, Adams-Haduch JM, Sandkovsky G, Sordillo E, Polsky B, Peleg AY, Bhussar MK, Doi Y. 2011. Risk factors and outcome of extended-spectrum beta-lactamaseproducing Enterobacter cloacae bloodstream infections. Int. J. Antimicrob. Agents 37:26-32.
-
(2011)
Int. J. Antimicrob. Agents
, vol.37
, pp. 26-32
-
-
Qureshi, Z.A.1
Paterson, D.L.2
Pakstis, D.L.3
Adams-Haduch, J.M.4
Sandkovsky, G.5
Sordillo, E.6
Polsky, B.7
Peleg, A.Y.8
Bhussar, M.K.9
Doi, Y.10
-
33
-
-
74549120901
-
Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections
-
Azap OK, Arslan H, Serefhanoglu K, Colakoglu S, Erdogan H, Timurkaynak F, Senger SS. 2010. Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections. Clin. Microbiol. Infect. 16:147-151.
-
(2010)
Clin. Microbiol. Infect.
, vol.16
, pp. 147-151
-
-
Azap, O.K.1
Arslan, H.2
Serefhanoglu, K.3
Colakoglu, S.4
Erdogan, H.5
Timurkaynak, F.6
Senger, S.S.7
-
34
-
-
84873638279
-
Community-associated extendedspectrum beta-lactamase-producing Escherichia coli infection in the United States
-
Doi Y, Park YS, Rivera JI, Adams-Haduch JM, Hingwe A, Sordillo EM, Lewis JS, II, Howard WJ, Johnson LE, Polsky B, Jorgensen JH, Richter SS, Shutt KA, Paterson DL. 2013. Community-associated extendedspectrum beta-lactamase- producing Escherichia coli infection in the United States. Clin. Infect. Dis. 56:641-648.
-
(2013)
Clin. Infect. Dis.
, vol.56
, pp. 641-648
-
-
Doi, Y.1
Park, Y.S.2
Rivera, J.I.3
Adams-Haduch, J.M.4
Hingwe, A.5
Sordillo, E.M.6
Lewis, J.S.7
Howard, W.J.8
Johnson, L.E.9
Polsky, B.10
Jorgensen, J.H.11
Richter, S.S.12
Shutt, K.A.13
Paterson, D.L.14
-
35
-
-
77954707306
-
Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant e
-
Johnson JR, Johnston B, Clabots C, Kuskowski MA, Castanheira M. 2010. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin. Infect. Dis. 51:286-294.
-
(2010)
Coli Infections in the United States. Clin. Infect. Dis.
, vol.51
, pp. 286-294
-
-
Johnson, J.R.1
Johnston, B.2
Clabots, C.3
Kuskowski, M.A.4
Castanheira, M.5
|